As of May 26
| +0.45 / +0.65%|
The 3 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 69.00, with a high estimate of 88.00 and a low estimate of 68.00. The median estimate represents a -1.22% decrease from the last price of 69.85.
The current consensus among 5 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.